메뉴 건너뛰기




Volumn 199, Issue 1-3, 2006, Pages 265-267

Biomaterial regulations for tissue engineering

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL CONTROL;

EID: 33746674345     PISSN: 00119164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.desal.2006.03.172     Document Type: Article
Times cited : (3)

References (24)
  • 1
    • 33746697092 scopus 로고    scopus 로고
    • EU directive 2003/94/EC on good manufacturing practice, 8 October 2003.
  • 2
    • 33746744225 scopus 로고    scopus 로고
    • US FDA; Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs, 21CFR Part 210.
  • 3
    • 33746709825 scopus 로고    scopus 로고
    • US FDA; cGMP for finished pharmaceuticals, 21 CFR Part 211.
  • 4
    • 33746748007 scopus 로고    scopus 로고
    • US FDA; Regulations for biological products, 21 CFR, Part 600-680.
  • 5
    • 33746663386 scopus 로고    scopus 로고
    • US FDA. 21 CFR Parts 16, 1270 and 1271 Current good tissue practice for manufacturers of human cellular and tissue-based products, 2004.
  • 6
    • 33746681711 scopus 로고    scopus 로고
    • EU Directive 2004/23/EC on quality and safety for the donation, procurement, testing, processing, preservation, storage, distribution of human tissues and cells, 31 March 2004.
  • 7
    • 33746695249 scopus 로고    scopus 로고
    • EU Proposal for a Regulation of the European parliament and of the council on advanced therapy medicinal products, 16.Nov. 2005.
  • 8
    • 33746732850 scopus 로고    scopus 로고
    • EU Directive 93/42/EEC of 14 June 1993 concerning medical devices.
  • 9
    • 33746701228 scopus 로고    scopus 로고
    • ISO EN DIN 9001 Standard, Quality management systems, 2000.
  • 10
    • 33746771928 scopus 로고    scopus 로고
    • ISO EN DIN 13485 Standard, Medical devices quality management systems, 2003.
  • 11
    • 33746662123 scopus 로고    scopus 로고
    • US FDA, Quality system regulation. 21 CFR Part 820.
  • 12
    • 0036296477 scopus 로고    scopus 로고
    • Emerging design principles in biomaterials and scaffolds for tissue engineering
    • Griffith G.L. Emerging design principles in biomaterials and scaffolds for tissue engineering. Ann. N.Y. Acad. Sci. 961 (2002) 83-95
    • (2002) Ann. N.Y. Acad. Sci. , vol.961 , pp. 83-95
    • Griffith, G.L.1
  • 13
    • 33746762781 scopus 로고    scopus 로고
    • Chapter 1031, The biocompatibility of materials used in drug containers, medical devices and implants, United States Pharmacopoeia, USP 28, 2005.
  • 14
    • 33746725808 scopus 로고    scopus 로고
    • Chapter 87, Biological reactivity tests in vitro; USP 28; 2005.
  • 15
    • 33746724590 scopus 로고    scopus 로고
    • Chapter 88: Biological reactivity tests in vivo; USP 28; 2005.
  • 16
    • 33746704221 scopus 로고    scopus 로고
    • Chapter 3: Materials for Containers, and Containers; E.P., 4th edition, 2002.
  • 17
    • 33746745181 scopus 로고    scopus 로고
    • ISO EN AAMI DIN 10993 Standard: Biological evaluation of medical devices.
  • 18
    • 33746669829 scopus 로고    scopus 로고
    • ASTM D1239-98, Test method for resistance of plastics films to extract by chemicals.
  • 19
    • 33746710221 scopus 로고    scopus 로고
    • ASTM F2150-02e1, Guide for characterization and testing of biomaterial scaffolds used in tissue-engineered medical products.
  • 20
    • 33746768640 scopus 로고    scopus 로고
    • National Institute of Standards and Technology(NIST), Polymers Division; Biomaterials Group; http://polymers.msel.nist.gov/researcharea/biomaterials/index.html
  • 21
    • 33746706077 scopus 로고    scopus 로고
    • US FDA. Indirect food additives: Polymers. 21 CFR, Part 177.
  • 24
    • 33746675512 scopus 로고    scopus 로고
    • EN DIN 10088 Standard: Stainless steel, 1995.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.